-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$4.50-37.15% Downside
G1 Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover G1 Therapeutics, Inc.?
G1 Therapeutics, Inc. has been rated by research analysts at Needham, H.C. Wainwright in the past 90 days.